Literature DB >> 11144902

Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report.

D G Bostwick1, R Montironi, I A Sesterhenn.   

Abstract

High-grade prostatic intraepithelial neoplasia (PIN) is the most likely precursor of prostatic carcinoma. PIN has a high predictive value as a marker for carcinoma, and its identification in biopsy specimens warrants repeat biopsy for concurrent or subsequent carcinoma. The only methods of detection are biopsy and transurethral resection; PIN does not significantly elevate serum PSA concentration or its derivatives, nor does it induce a palpable mass, and cannot be detected by ultrasound. Androgen deprivation therapy decreases the prevalence and extent of PIN, suggesting that this form of treatment may play a role in chemoprevention. Radiation therapy is also associated with a decreased incidence of PIN.

Entities:  

Mesh:

Year:  2000        PMID: 11144902     DOI: 10.1080/003655900750169266

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  5 in total

Review 1.  My approach to intraductal lesions of the prostate gland.

Authors:  M Pickup; T H Van der Kwast
Journal:  J Clin Pathol       Date:  2007-01-19       Impact factor: 3.411

Review 2.  Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.

Authors:  Maria Destouni; Andreas C Lazaris; Vasiliki Tzelepi
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

3.  Prostatic intraepithelial neoplasia in genetically engineered mice.

Authors:  Jae-Hak Park; Judy E Walls; Jose J Galvez; Minjung Kim; Cory Abate-Shen; Michael M Shen; Robert D Cardiff
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 4.  Chemoprevention of carcinoma prostate: a review.

Authors:  M S Ansari; N P Gupta; A K Hemal
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 5.  Dealing with non-cancerous findings on prostate biopsy.

Authors:  Timothy C Brand; Gregory P Thibault; Joseph W Basler
Journal:  Curr Urol Rep       Date:  2006-05       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.